modality platform multimaging software (ImaBiotech)
90
Structured Review
ImaBiotech
modality platform multimaging software
Modality Platform Multimaging Software, supplied by ImaBiotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/modality+platform+multimaging+software/multimaging+1+2+software/pm30933897-203-8-7
Average 90 stars, based on 1 article reviews
Modality Platform Multimaging Software, supplied by ImaBiotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/modality+platform+multimaging+software/multimaging+1+2+software/pm30933897-203-8-7
Average 90 stars, based on 1 article reviews
modality platform multimaging software - by Bioz Stars,
2026-11
90/100 stars
Images
Related Articles
other:Article Title: GNS561, a clinical-stage PPT1 inhibitor, is efficient against hepatocellular carcinoma via modulation of lysosomal functions Article Snippet: Article Title: Early Life to Adult Brain Lipidome Dynamic: A Temporospatial Study Investigating Dietary Polar Lipid Supplementation Efficacy Article Snippet: Processing and analysis of the MALDI-MSI datasets was performed by Article Title: Tumor Distribution by Quantitative Mass Spectrometry Imaging of the Inhibitor of Apoptosis Protein Antagonist Xevinapant in Patients with Resectable Squamous Cell Carcinoma of the Head and Neck (EudraCT Number: 2014-004655-31). Article Snippet: As tumors are very heterogeneous, investigating the penetration and concentration of an anticancer drug in different histological regions of a tumor is key to evaluate the efficacy, to improve the pharmacokinetics/pharmacodynamics (PK/PD) relationship evaluation, and to confirm the adequacy of the dose regimen.. Quantitative mass spectrometry imaging (QMSI) allows for the determination of the tissue distribution of drugs, metabolites, and biomarkers to support quick and precise evaluation of drug efficacy and safety in a single experiment.. QMSI was applied in a preoperative window-of-opportunity (WoO) study of the inhibitor of apoptosis protein antagonist xevinapant (Debio 1143) in patients with resectable squamous cell carcinoma of the head and neck (SCCHN). Article Title: Caffeine intake exerts dual genome-wide effects on hippocampal metabolism and learning-dependent transcription Article Snippet: All data processing, visualization, and quantification were performed using Article Title: GNS561, a clinical-stage PPT1 inhibitor, is efficient against hepatocellular carcinoma via modulation of lysosomal functions. Article Snippet: Article Title: Development of a First-in-Class Click Chemistry–Based Cancer Therapeutic, from Preclinical Evaluation to a First-in-Human Dose Escalation Clinical Trial Article Snippet: MSI data were analyzed using Software:Article Title: Targeted Expression of TGFBIp Peptides in Mouse and Human Tissue by MALDI-Mass Spectrometry Imaging Article Snippet: .. Image treatment including optical, molecular images and overlays were realized with |